The ascent of the blessed: Regulatory issues on health effects and health claims for probiotics in Europe and the rest of the world

Beneficial Microbes

Volumn 9, Issue 5, 2018, Pages 717-723

  Dronkers, T M G ^a   Krist, L ^a   Vanoverveld, F J ^a   Rijkers, G T ^a  

^a University College Roosevelt   (Netherlands)

Author keywords

Bifidobacterium; Clinical trials; EFSA; Lactobacillus

Indexed keywords

PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; DRUG EFFECT; EUROPE; EVIDENCE BASED PRACTICE; HUMAN; POPULATION RISK; RISK REDUCTION; TREND STUDY; ANALYSIS; CHEMISTRY; CLINICAL TRIAL (TOPIC); DEVELOPING COUNTRY; DIETARY SUPPLEMENT; DRUG CONTROL; DRUG LABELING; LEGISLATION AND JURISPRUDENCE; ORGANIZATION AND MANAGEMENT; STANDARDS;

CLINICAL TRIALS AS TOPIC; DEVELOPED COUNTRIES; DIETARY SUPPLEMENTS; DRUG AND NARCOTIC CONTROL; DRUG LABELING; EUROPE; HUMANS; PROBIOTICS;

EID: 85054493441     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2017.0196     Document Type: Article

References (39)

1. Amagase, H., 2008. Current marketplace for probiotics: A Japanese perspective. Clinical and Infectious Diseases 46, Suppl. 2: S73-S75.
2. Arroyo, R., Martín, V., Maldonado, A., Jiménez, E., Fernández, L. and Rodríguez, J.M., 2010. Treatment of infectious mastitis during lactation: Antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clinical and Infectious Diseases 50: 1551-1558.
3. Asp, N.-G. and Bryngelsson, S., 2008 Health claims in Europe: new legislation and PASSCLAIM for substantiation. Journal of Nutrition 138: 1210S-1215S.
4. Binnendijk, K.H. and Rijkers, G.T., 2013. What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics. Beneficial Microbes 4: 223-230.
5. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2010. Scientific Opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 8: 1763.
6. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2013a. Scientific Opinion on the substantiation of a health claim related to Yestimun® and defence against pathogens in the upper respiratory tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 11: 3159.
7. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2013b. Scientific Opinion on the substantiation of a health claim related to Lactobacillus rhamnosus GG and maintenance of normal defecation during antibiotic treatment pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 11: 3256.
8. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2013c. Scientific Opinion on the substantiation of a health claim related to Transitech® and improvement of bowel function which is maintained after cessation of consumption of the food pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 11: 3258.
9. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2013d. Scientific Opinion on the substantiation of a health claim related to hydroxyanthracene derivatives and improvement of bowel function pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 11: 3412.
10. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2014a. Scientific Opinion on the substantiation of a health claim related to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 and reducing intestinal discomfort pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 12: 3658.
11. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2014c. Scientific Opinion on the substantiation of a health claim related to 'Lactobacillus plantarum TENSIA® in the semi-hard Edam-Type "heart cheese" of Harmony™' and maintenance of normal blood pressure pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 12: 3842.
12. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2015a. Scientific Opinion on the substantiation of a health claim related to Bifidobacterium bifidum CNCM I-3426 and defence against pathogens in the upper respiratory tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 13: 4094.
13. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2015b. Scientific Opinion on the substantiation of a health claim related to SYNBIO®, a combination of Lactobacillus rhamnosus IMC 501® and Lactobacillus paracasei IMC 502®, and maintenance of normal defecation pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 13: 4095.
14. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2016a. Lactobacillus plantarum 299v and an increase of non-haem iron absorption: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 14: 4550.
15. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2016b. Scientific opinion on low-fat fermented milk with a combination of fructo-oligosaccharides and live Lactobacillus rhamnosus GG (ATCC 53103), Streptococcus thermophilus(Z57) and Lactobacillus bulgaricus(LB2), and defence against reactivation of Herpes simplex virus in the orolabial epithelia: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 14: 4538.
16. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2017. Scientific Opinion on 'Nutrimune®' and immune defence against pathogens in the gastrointestinal and upper respiratory tracts: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 15: 4679.
17. EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), 2017a. Scientific Opinion on the Lactobacillus fermentum CECT 5716 and a reduction of the Staphylococcus load in breast milk which reduces the risk of infectious mastitis: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 15: 4917.
18. European Commission (EC), 2017. EU Register of nutrition and health claims made on foods. Available at: https://tinyurl.com/y7sauo7d.
19. European Food Safety Authority (EFSA), 2015. Shaping the future of food safety, together: proceedings of the 2nd EFSA Scientific Conference. Milan, Italy, 14-16 October 2015. EFSA Journal 13: 1310.
20. European Food Safety Authority (EFSA), 2017. Outcome of a public consultation on the draft scientific and technical guidance for the preparation and presentation of a health claim application. EFSA Supporting Publication 2017: EN-1159.
21. Fernández, L., Cárdenas, N., Arroyo, R., Manzano, S., Jiménez, E., Martín, V. and Rodríguez, J.M., 2016. Prevention of infectious mastitis by oral administration of Lactobacillus salivarius PS2 during late pregnancy. Clinical and Infectious Diseases 62: 568-573.
22. Food Directorate, Health Products and Food Branch, 2009. Guidance document -The use of probiotic microorganisms in food. Available at: https://tinyurl.com/ydgtjgag.
23. Health Canada, 2009. Accepted Claims about the Nature of Probiotic Microorganisms in Food. Available at: http://tinyurl.com/ya3w96gn.
24. Hoffmann, D.E., Fraser, C.M., Palumbo, F., Ravel, J., Rowthorn, V. and Schwartz, J., 2014. Probiotics: Achieving a better regulatory fit. Food Drug Law Journal 69: 237-272.
25. Hoffmann, D.E., Fraser, C.M., Palumbo, F., Ravel, J., Rowthorn, V. and Schwartz, J., 2016. Final report federal regulation of probiotics: An analysis of the existing regulatory framework and recommendations for alternative frameworks, November 15, 2012. Available at: https://tinyurl.com/y93325mb.
26. Hoffmann, D.E., Fraser, C.M., Palumbo, F.B., Ravel, J., Rothenberg, K., Rowthorn, V. and Schwartz, J., 2013. Probiotics: finding the right regulatory balance. Science 342: 314-315.
27. Indian Council of Medical Research, 2011. ICMR-DBT guidelines for evaluation of probiotics in food. Available at: http://tinyurl.com/ycbkph86.
28. Jahanfar, S., Ng, C.J. and Teng, C.L., 2013. Antibiotics for mastitis in breastfeeding women. Cochrane Database Systematic Reviews 28: 005458.
29. Kamioka, H., Tsutani, K., Origasa, H., Yoshizaki, T., Kitayuguchi, J., Shimada, M., Tang, W. and Takano-Ohmuro, H., 2017. Quality of systematic reviews of the foods with function claims registered at the consumer affairs agency web site in Japan: A prospective systematic review. Nutrition Research 40: 21-31.
30. Kondo, J., Xiao, J.Z., Shirahata, A., Baba, M., Abe, A., Ogawa, K. and Shimoda, T., 2013. Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients receiving enteral feeding. World Journal of Gastroenterology 19: 2162-2170.
31. Lee, Y.K., Conway, P., Pettersson, S., Nair, G.B., Surono, I., Egayanti, Y. and Amarra, M.S., 2017. ILSI Southeast Asia Region conference proceedings: The gut, its microbes and health: Relevance for Asia. Asia Pacific Journal of Clinical Nutrition 26: 957-971.
32. Ministry for Primary Industries, 2016. Global regulatory environment of health claims on foods. MPI Technical Paper No. 2016/16. Available at: https://tinyurl.com/yaoeooh6.
33. Patro, J.N., Ramachandran, P., Barnaba, T., Mammel, M.K., Lewis, J.L. and Elkins, C.A., 2016. Culture-independent metagenomic surveillance of commercially available probiotics with high-Throughput next-generation sequencing. mSphere 1: 00057-16.
34. Saldanha, L.G., 2008. US Food and Drug Administration regulations governing label claims for food products, including probiotics. Clinical Infectious Diseases 46, Suppl. 2: S119-S121.
35. Schweizerische Bundesamt für Lebensmittelsicherheit und Veterinärwesen (FSVO/BLV), 2018. Zugelassene gesundheitsbezogene Angaben gemäss Art. 29g der Verordnung über die Kennzeichnung und Anpreisung von Lebensmitteln (LKV). (LKV; SR 817.022.21). Available at: https://tinyurl.com/ycvkylld.
36. Shimizu, M., 2012. Functional food in Japan: current status and future of gut-modulating food. Journal of Food and Drug Analysis 20, Suppl. 1: 213-216.
37. Stringueta, P.S., Da Penha Henriques do Amaral, M., Brumano, L.P., Santana Pereira, M.C. and De Oliveira Pinto, M.A., 2012. Public health policies and functional property claims for food in Brazil. In: Eissa, A.A. (ed.) Structure and function of food engineering agricultural and biological sciences. Intech Publisher, Rijeka, Croatia, pp. 307-336.
38. US Food and Drug Administration (FDA), 2017. Authorized health claims that meet the Significant Scientific Agreement (SSA) standard. Available at: https://tinyurl.com/y6w2cjxg.
39. Yang, Y., 2008. Scientific substantiation of functional food health claims in China. Journal of Nutrition 138: 1199S -1205S.